Keyphrases
Bleeding
100%
Vitamin K
100%
Carboxylase
100%
Gamma-glutamyltransferase
100%
Carboxylation
36%
Coagulation Factors
27%
Clinical Phenotype
18%
Cell-based
18%
Bleeding Disorders
18%
Genotype
9%
Comorbid
9%
Fatal Outcome
9%
Clinical Consequences
9%
Physiological Concentrations
9%
HEK293 Cells
9%
Keutel Syndrome
9%
Genome Editing
9%
Causative mutation
9%
Coagulation Abnormalities
9%
Stably Expressing
9%
Coagulation Factor Deficiency
9%
Cerebral Bleeding
9%
K Concentration
9%
Cas9 Protein
9%
Maladies
9%
Reporter Protein
9%
Functional Defects
9%
INIS
mutations
100%
vitamin k
100%
carboxylase
100%
patients
41%
proteins
41%
matrices
33%
carboxylation
33%
phenotype
16%
concentration
16%
mutants
16%
tools
8%
correlations
8%
comparative evaluations
8%
genes
8%
genotype
8%
in vivo
8%
defects
8%
Pharmacology, Toxicology and Pharmaceutical Science
Carboxylase
100%
Vitamin K Dependent Carboxylase
100%
Blood Clotting Factor
36%
Vitamin K Group
36%
4 Carboxyglutamic Acid
36%
Syndrome
18%
Bleeding Disorder
18%
Bleeding
9%
Fatality
9%
Neuroscience
Carboxylase
100%
Vitamin K Dependent Carboxylase
100%
Blood Clotting Factor
36%
Vitamin K
36%
4 Carboxyglutamic Acid
36%
Cell-Based Assays
18%
In Vivo
9%
CRISPR
9%
Biochemistry, Genetics and Molecular Biology
Gamma-Glutamyl Carboxylase
100%
Vitamin K
100%
Carboxylation
36%
Blood Coagulation Factor
27%
Wild Type
9%
Vitamin K-Dependent Coagulation Factor
9%
Genome Editing
9%
CRISPR/Cas9
9%